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740Background: Many general thoracic surgeons are learning robotic pulmonary resection.
Methods: We retrospectively compared results of completely portal robot lobectomy with 4 arms (CPRL-4)
against propensity-matched controls and results after technical changes to CPRL-4.
Results: In 14 months, 168 patients underwent robotic pulmonary resection: 7 had metastatic pleural disease, 13
had conversion to open procedures, and 148 had completion robotically (106 lobectomies, 26 wedge resections,
16 segmentectomies). All patients underwent R0 resection and removal of all visible lymph nodes (median of 5
N2, 3 N1 nodal stations, 17 lymph nodes). The 106 patients who underwent CPRL-4 were compared with 318
propensity-matched patients who underwent lobectomy by rib- and nerve-sparing thoracotomy. The robotic
group had reduced morbidity (27% vs 38%; P¼ .05), lower mortality (0% vs 3.1%; P¼ .11), improved mental
quality of life (53 vs 40; P<.001), and shorter hospital stay (2.0 vs 4.0 days; P ¼ .02). Results of CPRL-4 after
technical modifications led to reductions in median operative time (3.7 vs 1.9 hours; P<.001) and conversion
(12/62 vs 1/106; P<.001). Technical improvements were addition of fourth robotic arm for retraction, vessel
loop to guide the stapler, tumor removal above the diaphragm, and carbon dioxide insufflation.
Conclusions: The newly refined CPRL-4 is safe and yields an R0 resection with complete lymph node removal.
It has lower morbidity, mortality, shorter hospital stay, and better quality of life than rib- and nerve-sparing
thoracotomy. Technical advances are possible to shorten and improve the operation. (J Thorac Cardiovasc
Surg 2011;142:740-6)The increasing use of robotic surgical systems worldwide is
undeniable. A recent article in The Wall Street Journal1 ad-
dressed the problems of learning robotic surgery and also
the issue of credentialing for surgeons already in practice.
Similarly, an article in The New England Journal of Medi-
cine2 in August 2010 estimated the cost of the expanding
use of robotic surgery in other specialties. The benefit that
any new surgical technique offers should be demonstrated
in carefully designed prospective studies; however, the
rapid paradigm shift toward minimally invasive surgery,
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The Journal of Thoracic and Cardiovascular Surgrobotic surgery, has occurred without any prospective, ran-
domized trials. The lack of equipoise makes these types of
trials unlikely. Robotics is rapidly growing because of the
improvements in 3-dimensional visualization, the technical
advantages of small-wristed instruments, and the ability to
perform an outstanding lymph node dissection. Studies
have shown the safety of robotic pulmonary resection, but
none have compared outcomes with those of rib-sparing,
nerve-sparing thoracotomy.3-6 In this study, we report our
experience with robotic pulmonary resection with a newly
modified technique that features a completely portal (all
small incisions) 4-arm robotic operation (CPRL-4) with
carbon dioxide insufflation and compare the short-term out-
comes with those of patients undergoing resection through
a rib- and nerve-sparing thoracotomy. Importantly, this is
not a selected series but rather a consecutive series of pa-
tients who had clinically apparent resectable non–small
cell lung cancer. Therefore patients who underwent VATS
lobectomy were not chosen as a comparison group, because
it was only offered to selected patients (those with tumors
<4 cm and without N1 disease).MATERIALS AND METHODS
This is a retrospective cohort study of a consecutive series of patients
entered into a prospective database during a 14-month period who under-
went attempted completely portal robotic pulmonary resection. Patients
had apparent resectable lesions that were biopsy proven or were highly sus-
pect for non–small cell lung cancer. All operations were performed byery c October 2011
FIGURE 1. The completely portal robotic lobectomy with 4 robotic arms
technique developed in this study is shown. It features entering the pleural
space with a 5-mm port anteriorly in the midaxillary line (MAL) over the
top of the 7th rib and then using a 5-mm video-assisted thoracoscopic sur-
gery camera to enable the surgeon to make all other incisions on the basis
internal anatomy. The circled numbers represent the robotic arms used,
C indicates the camera port, and A indicates the 15-mm access port (which
can also be placed between the camera and robotic arm 2 if space is not ad-
equatemore anteriorly). Note that robotic arm 3 is a 5-mm port, robotic arm
2 is an 8-mm port, the camera can be an 8- or 12-mm port, depending on the
camera used, and robotic arm 1 is a 12-mm port. The area with the dashed
lines is the area in which no incisions are made and is the most posterior
third of the area between the mid spine and the posterior edge of the
scapula.
Abbreviations and Acronyms
CPRL-4 ¼ completely portal robotic lobectomy
with 4 robotic arms
SF-12 ¼ 12-item Short Form Health Survey
VATS ¼ video-assisted thoracoscopic surgery
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most all patients who in the past would have been offered resection through
a thoracotomy (patients who had undergone computed tomographic scan-
ning, integrated positron emission tomographic and computed tomographic
scanning, and pulmonary function and cardiac stress testing and who were
mediastinal [N2] lymph node negative and had adequate cardiopulmonary
reserve, as previously described by us7,8) were now offered robotic
resection. The only patients who were not offered robotic surgery who in
the past would have been offered thoracotomy were those who had
tumor in the segmental bronchus or more proximal, those who had chest
wall involvement that required rib resection, and those who refused
a robotic operation. Neither the size of the lesion, its location, the
presence of N1 disease, nor the use of preoperative radiation or
chemotherapy contraindicated the offer of robotic pulmonary surgery in
this study.
The nerve- and rib-sparing thoracotomy that was used in this series for
the matched control patients has been previously described by us else-
where.9-12 It has been corroborated by other centers as less painful than
standard thoracotomy.13,14 This type of thoracotomy technique was
compared with the newly developed completely portal four arm robotic
technique (CPRL-4) described in Appendix 1 (Figure 1).
Conversions from a completely portal robotic technique to an open tech-
nique were done for several reasons. A time limit of approximately 4 hours
(as we learned how to do the operation) was set to prevent patient injury
from prolonged anesthesia and to limit both operating room personnel
and surgeon frustration. After 4 hours, patients had conversion to open sur-
gery or to VATS if the operation was not near completion. Other indications
for opening were bleeding that could not be controlled robotically and the
inability to enter the pleural space because of pleural symphysis.
The University of Alabama at Birmingham’s institutional review board
approved this protocol as well as the prospective database used to collect
information for this study. Patient consent was waived for inclusion in
this individual study; however, consent was both required and obtained
to enter patient data into the prospective database.
Definitions
Morbidity was defined according to The Society of Thoracic Surgeons
database’s definitions (version 2.8), with the exception of air leak. Opera-
tive mortality was defined as death from any cause within 30 days after sur-
gery or before discharge. The operative time was defined as the time from
skin incision until skin closure and thus included all robotic docking and
undocking times, along with time spent waiting for frozen-section analysis.
A numeric pain scorewas assessed on a scale ranging from 0 (no pain) to 10
(extreme pain). Quality of life was defined as the subject’s functioning and
well-being in the physical, psychologic, and social domains in relation to
disease and treatment. In this study, the participants’ quality of life was
measured with the 12-item Short FormHealth Survey (SF-12) with supple-
mental questions about pain control.15 The SF-12, a validated shorter alter-
native to the 36-item survey, consists of a physical component summary
and a mental component summary.16-18 Subjects completed the SF-12 pre-
operatively and at both 3 weeks and 4 months postoperatively either at
a clinic appointment or by mail. SF-12 scores were computed separately
for the physical and mental components of the survey and compared
with adjusted values, with 50 representing the average or norm-basedThe Journal of Thoracic and Cascore. Quality of life information was obtained from patients at both
3 weeks and 4 months after surgery.
Statistical Analysis
Data were exported from Excel (Microsoft Corp, Redmond, Wash) to
SAS v. 9.1 (SAS Institute, Inc, Cary, NC) software. Descriptive statistics
were used to estimate the frequencies of the categoric variables and the
medians of the continuous variables. Differences between study groups
were assessed with the use of 2-sided Fisher’s Exact tests and c2 tests for
categoric variables and of independent sample Student t tests for normally
distributed continuous variables.
Propensity score analysis was carried out in this study to estimate the
probability that a patient might undergo a robotic procedure versus thora-
cotomy to eliminate the effects of lack of randomization and selection
bias.19 A logistic regression analysis of several preoperative variables
(laterality of tumor, preoperative Eastern Cooperative Oncology Group
performance status, sex, age [ 5 years], forced expiratory volume in 1
second [ 5%], smoking status, history of neoadjuvant therapy, and size
of the tumor resected) was performed to generate a single propensity score
for each patient. Patients selected for matching were selected from a data-
base of more than 3000 patients (595 elective lobectomies) operated on be-
tween 2006 and 2009 by the same general thoracic surgeon who performed
all the robotic operations, CPRL-4 procedures, and thoracotomies in this
study (R.J.C.).RESULTS
Between February 2010 and April 2011, a total of 168 pa-
tients underwent attempted robotic pulmonary resection for
clinically staged resectable disease. There were 55 patientsrdiovascular Surgery c Volume 142, Number 4 741
TABLE 1. Characteristics of the 168 patients in this study and a comparison of the 106 patients who underwent completely portal robotic
lobectomy with 4 robotic arms compared with 317 patients (propensity-matched controls) who underwent lobectomy with a rib- and nerve-
sparing thoracotomy
All patients with attempted
robotic operation (N ¼ 168)
Robotic lobectomy (N ¼ 106,
excludes 13 conversions)
Rib-, nerve-sparing
thoracotomy (N ¼ 318)
Age* (y, median and range) 67 (21–87) 66 (31–85) 66 (26–83)
Male sex* (no.) 75 (45%) 51 (48%) 150 (47%)
Ethnicity (no.)
White 146 (87%) 92 (88%) 273 (86%)
Black 21 (13%) 13 (12%) 44 (14%)
Other 1 (<1%) 1 (1%) 1 (<1%)
Current smoking or history* (smoking within 6 mo
of surgery and>100 cigarettes in lifetime, no.)
32 (19%) 18 (17%) 51 (16%)
Forced expiratory volume in 1 s* (%, median  SD) 83.9  14.5 84.1  12.0 85.4  13
Diffusing capacity of lung for carbon
monoxide (adjusted%, median  SD)
77.5  13.5 76.2  11.4 80.2  12.8
Eastern Cooperative Oncology Group performance
status* (median and range)
1 (0–3) 1 (0–3) 1 (0–3)
Neoadjuvant therapy* (no.) 6 (4%) 5 (5%) 16 (5%)
History of hypertension (no.) 82 (49%) 73 (69%) 191 (60%)
History of cardiac disease (no.) 36 (21%) 33 (32%) 89 (28%)
History of diabetes mellitus (no.) 17 (10%) 16 (15%) 35 (11%)
Previous ipsilateral operation (no.) 2 (1%) 2 (2%) 9 (3%)
American Society of Anesthesiologists
score, (median and range)
3 (2–3) 3 (2–3) 3 (1–3)
Size of primary tumor* (cm, median and range) 3.9 (0.7–9.4) 3.7 (0.7–9.4) 3.6 (0.5–20)
*Variables used for propensity matching. No statistically significant differences were observed in the aforementioned unmatched variables.
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section during this time frame (because of the need for
sleeve resections, chest wall resection, Pancoast tumors,
etc). The characteristics of these 168 patients are shown in
Table 1, which also compares the characteristics of the 106
patientswhoactually underwent completeCPRL-4 and those
of the 318 (3:1 matched) control patients who underwent lo-
bectomy with nerve- and rib-sparing thoracotomy. During
the operation, 7 patients were noted after robotic magnified
inspection to have unsuspected lesions on the pleura that
were biopsy proven as cancer. Thirteen procedures were
converted to open (11 lobectomies, 1 segmentectomy, and
1 wedge), and 148 patients underwent a complete robotic
resection (106 underwent lobectomy, 26 underwent wedge
resection, and 16 underwent segmentectomy).
Table 1 shows that therewere no significant differences in
the patient characteristics and risk factors between the 2
groups in the unmatched variables. Table 2 illustrates the
outcome differences for the 106 patients who underwent
CPRL-4 and 318 matched patients who underwent rib-
and nerve-sparing thoracotomy and lobectomy. It shows
that there was no statistically significant difference in the to-
tal number of lymph nodes removed or in the median num-
ber of N2 or N1 lymph node stations assessed. Additionally,
it shows that there was significantly less blood loss (35 mL
vs 90 mL; P ¼ .03), shorter chest tube duration (1.5 vs 3.0
days; P< .001), shorter hospital stay (2 days vs 4 days;742 The Journal of Thoracic and Cardiovascular SurgP ¼.02), lower incidence of morbidity (27% vs 38%;
P ¼ .05), and lower 3-week postoperative pain score (2.5
vs 4.4; P ¼ .04) in the CPRL-4 group than in the open
group.
Postoperative morbidities included transient atrial fibril-
lation in 12 patients (all were successfully treated with
calcium-channel blockers and discharged home in sinus
rhythm), air leak in 10 patients (3 patients were discharged
home on postoperative day 3 with a chest tube and with
a digital air leak system), chylothorax in 2 patients (both pa-
tients successfully treated with a medium-chain triglyceride
diet), pneumothorax after chest tube removal in 2 patients
(both patients required replacement of the chest tube, and
these tubes were removed within 48 hours), subcutaneous
emphysema in 6 patients (treated by adding suction to the
chest tubes), and respiratory distress requiring reintubation
in 1 patient (who recovered within 1 week and was dis-
charged home on postoperative day 7).
A significantly higher average mental quality of life
score was observed 3 weeks postoperatively in patients
who underwent the CPRL-4 robotic lobectomy relative
to patients who underwent an open rib- and nerve-
sparing lobectomy (53.5 vs 40.3; P<.001, respectively).
A similar trend was observed for physical quality of life
score at 3 weeks (40.1 vs 34.1; P ¼ .07, respectively);
however, the latter difference did not achieve a statistical
significance. The 4-month postoperative mental andery c October 2011
TABLE 2. Comparison of the outcomes of the 106 patients who underwent completely portal robotic lobectomywith 4 robotic arms comparedwith




thoracotomy (N ¼ 318) P value
Estimated blood loss (mL, median  SD) 30  26 90  22 .03
Operative time (h, median  SD) 2.2  1.0 1.5  0.8 <.001
No. of mediastinal (N2) lymph node stations removed (median) 5 5 >.999
No. of mediastinal (N2) lymph nodes removed (median) 12 11 .906
No. of N1 lymph node stations removed (median) 3 3 >.999
No. of N1 lymph node removed (median) 5 4 .89
Chest tube duration (d, median and range) 1.5 (1–6) 3.0 (1–67) <.001
Hospital stay (d, median and range) 2.0 (1–7) 4.0 (1–67) .01
Morbidity (no.) 28 (27%) 120 (38%) .05
Operative mortality (no.) 0 11 (3%) .11
Verbal pain score 3 wk postoperatively (median and range) 2.5 (0–7) 4.4 (0–8) .04
FIGURE 2. Median operative times (skin incision to skin closure) for
completed completely portal robotic lobectomy with 4 robotic arms
(CPRL) with time in sequential order.
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between the 2 groups.
Thirteen patients had conversion to open procedures dur-
ing robotic pulmonary resection (11 during CPRL-4 and 1
each during wedge resection and segmentectomy). The rea-
sons for conversions were as follows: 4 patients had inva-
sive tumors (2 into the other lobe, 1 into the pericardium,
and 1 into the chest wall), there were time limitations in 4
cases (all in our first 15 operations), 3 patients had calcified
lymph nodes on the pulmonary artery or bronchus that pre-
cluded safe dissection, and 2 patients had all other phases of
the lobectomy completed, but the pulmonary vein in 1 case
and a bronchus in the other could not be safely taken with
the stapler.
Two patients had conversion from a robotic approach to
thoracotomy because of vascular injury and bleeding. One
patient was undergoing a left upper lobectomy, and there
was an injury to the apical anterior trunk of the pulmonary
artery while a vessel loop was being placed around it. The
area was first packed robotically and confirmed by
a VATS camera to be hemostatic; the robot was then un-
docked, and a thoracotomy was performed in a nonurgent
manner. The lobectomy was completed, and the patient
did well and went home on postoperative day 4 without
the need for any blood transfusions. The second patient
was undergoing a posterior segmentectomy of the right up-
per lobe, and after safe ligation of the posterior segmental
artery and bronchus, there was significant bleeding during
completion of the operation by stapling the lung paren-
chyma. This bleeding necessitated a thoracotomy. This
patient went home on postoperative day 6 without any com-
plications or the need for blood transfusion, despite poor
pulmonary function.
Results of CPRL-4 after technical modifications show
a trend toward reduction in median operative time, as shown
in Figure 2, and reduction in conversion rate (12 of the first
62 operations [19%] and 1 in the last 106 [1%]; P<.001).The Journal of Thoracic and CaThe significant technical changes madewere as follows: ad-
dition of the fourth robotic arm posterior and use of a 5-mm
port so that the surgeon could retract the lung for himself or
herself; placement of a vessel loop around the artery, vein,
bronchus, and fissures to help guide the stapler; the removal
of the tumor above the diaphragm; and the use of carbon
dioxide insufflation.DISCUSSION
The results of this study show that robotic lobectomy is
safe. The surgeon can achieve an R0 resection in patients
with lung cancer, even those with large tumors (up to 9.4
cm in this series). In addition, an outstanding mediastinal
and hilar lymph node resection is achievable. The median
number of N2 mediastinal lymph node stations removed
was 5: stations 2R, 4R, 7, 8, and 9 in the right side of the
chest and stations 5, 6, 7, 8, and 9 in the left side of the chest.
There alsowas a median of 3 N1 hilar lymph nodes removed
(stations 10, 11, and 12). Important limitations, however, in-
clude and are not limited to cost concerns, the learningrdiovascular Surgery c Volume 142, Number 4 743
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lung, and the inability to obtain adequate robotic time in
many hospitals.
This study represents our first 14 months of experience
with robotic pulmonary resection. Our initial conversion
rate was high (12 of the first 62 operations vs only 1 in
the last 106). Importantly, all conversions were elective ex-
cept 2, and both of those patients did well and received no
blood transfusion. The causes for the high initial conversion
rate are multifactorial. First, we were developing our new
CPRL-4 procedure, so various port placements, instru-
ments, and robot positionings were tried. Second, this was
a consecutive series of patients, not the more typical series
of hand-picked patients with small peripheral lesions.
Third, we intentionally set a time limit of 4 hours for the op-
eration. This was done not only to protect patients from long
anesthetic times and to prevent pulmonary edema20 in the
dependent lung but also to maintain the confidence of the
entire operating room staff and to limit our frustration
with learning an entirely new way to operate. Once the op-
erative technique had solidified, only 1 of the last 106 pa-
tients had conversion to an open procedure, even though
many patients had previous thoracotomy, large tumors,
and preoperative radiation therapy and chemotherapy.
Reasons to perform robotic or VATS operations are
several-fold. New provocative data suggest immunologic
benefits to a minimally invasive, non–rib spreading opera-
tion, which may lead to improved survival for patients
with non–small cell lung cancer.21-24 These important
data (and the fact that we were unsatisfied with our lymph
node dissection during VATS) provided the impetus for us
even to try robotic pulmonary resection. Studies show that
patients who undergo minimally invasive lobectomy by
VATS have shorter hospital stay, less morbidity, quicker
recovery, quicker chest tube removal, and the better
delivery of adjuvant chemotherapy.25 We have argued and
still believe that that many of the advantages of minimally
invasive surgery are related more to the surgeon’s mindset
than to the chosen operative technique. Improved 5-year
survival and lessened morbidity, however, are important
reasons for all surgeons to adopt minimally invasive tech-
niques. These facts make the fervent debate between tho-
racic surgeons regarding robotic lobectomy versus VATS
lobectomy seem trivial and silly. Our ultimate goal as
general thoracic surgeons should be the same: a minimally
invasive, non–rib spreading approach for patients with lung
cancer that still provides all the oncologic benefits of sur-
gery by thoracotomy.
This study enrolled many patients who probably would
not have been offered VATS lobectomy at most institutions.
Most VATS studies select patients with small T1 or T2 N0
M0 (usually<3 cm) lesions.26,27 This is because the tumor
is removed though a 3- to 4-cm access incision most fre-
quently made between ribs 4 and 5 or 5 and 6. In contrast,744 The Journal of Thoracic and Cardiovascular Surga CPRL-4 uses a lower rib space for the removal of tumors
(one that VATS surgeons could use as well) between ribs 9
and 10 anteriorly. This permits the removal of larger tumors
(as large as 9.4 cm in this series). Robotic surgery, however,
clearly takes longer to set up (more trocars and ports are
used, and there is necessary docking time), has higher initial
capital costs, provides no lung palpation, and involves more
specialized equipment than VATS.
Previous reports have demonstrated the safety of robotic
pulmonary resection, although they have used very different
operative techniques. The technical differences are impor-
tant to the surgeon. Veronesi and associates20 in 2010 re-
cently reported the safety of a 4-arm robotically assisted
(not completely portal) lobectomy (with a 3- to 4-cm access
incision such as used by VATS surgeons) in 54 patients.
Ninan and coworkers28 in 2010 reported the effectiveness
of a completely portal robotic lobectomy with 3 arms in
74 patients. Gharagozloo and colleagues29 in 2009 reported
outcomes with a hybrid technique. Thus the literature shows
that robotic pulmonary resection is safe and oncologically
sound, allowing R0 resection with excellent lymph node re-
moval. Similar to VATS, there are several ways that robotic
resection can be performed. An international committee has
been formed and is writing a consensus paper regarding
agreed upon nomenclature and definitions for the different
types of robotic surgery (ie, robotically assisted, completely
portal, etc).
The adoption of the robot for pulmonary resection will
depend on several factors: the availability of the robotic
platform to the thoracic surgeon; the true cost of the opera-
tion; the measured and perceived benefits to the patient,
hospital, and surgeon; and the time it takes to perform the
operation. Most important, however, may be the surgeon’s
current enthusiasm for the VATS lobectomy that he or she
performs: minimally invasive surgery is unequivocally our
future. If a team is already adroit with VATS lobectomy
and believes that the lymph node dissection being attained
is adequate, the desire to add robotic pulmonary resection
to the armamentarium will be low. If lymph node dissection
during VATS lobectomy is, however, suboptimal and diffi-
cult to teach, as in our experience, then the desire for robotic
techniques will probably be high.
The strengths of this study are as follows: there was only
1 surgeon who performed all the open and robotic opera-
tions, and it was a consecutive series as opposed to highly
selected patients. The limitations of this study include the
following: it was single institutional; the procedure under-
went modifications during the first 20 operations; and
patients were told that the procedure was new and ‘‘less
invasive,’’ and this information may have biased the patients
during their reporting of their pain scores and quality of life
surveys.
In conclusion, this study demonstrates the safety, effi-
cacy, complete lymph node removal, and improved qualityery c October 2011
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cell lung cancer. Technical modifications are possible and
can lead to decreased operative times and improved teach-
ability, as well as decreasing patient morbidity and surgeon
frustration during the learning curve. Even though hospitals
are acquiring more robots for other specialties in addition to
thoracic surgery, the capital cost, service contract costs, and
equipment costs must be carefully considered and studied.
Patient selection is critical, especially during the learning
curve. In our opinion, there are few to any achievable
benefits of using a robotic system rather than VATS when
performing a sympathotomy for patients with hyperhidrosis
or a pulmonary wedge resection for tissue diagnosis for
patients with interstitial lung disease. Implementation of
a robotic system for the resection of mediastinal tumor or
for thymectomy in patients with myasthenia gravis is, how-
ever, of obvious potential utility. Although further studies
are needed, the explosion of the interest in robotics in gen-
eral thoracic surgery is real. Academic centers must unite
and organize to ensure the proper training of surgeons in
robotic techniques to protect patients and surgeons and to
form an agreed upon international nomenclature.References
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88:380-4.APPENDIX 1. Operative Description of CPRL-4
As shown in Figure 1, this new technique can be briefly
summarized. The pleural space is entered over the top of
the 7th rib with a 5-mm port in the midaxillary line, or as
anteriorly as possible, and guided by a 5-mm scope. A
5-mm VATS camera is used to ensure entry into the pleural
space, and warmed carbon dioxide is insufflated to drive the
diaphragm inferiorly. This incision will eventually be en-
larged to allow a 12-mm port, and it will serve as robotic
arm 1 (for right-sided operations). A paravertebral block
is performed posteriorly with a local anesthetic and a 21-
gauge needle from ribs 3 to 11. The needle is used to help
select the ideal location for the second incision, the most
posterior incision. The location chosen is 2 ribs below the
major fissure and as far posterior in the chest as possible,
just anterior to the spinal processes of the vertebral body.
A small 5-mm incision is made, and a 5-mm reusable metal
da Vinci trocar is placed. This will be the position for ro-
botic arm 3. The next few incisions are carefully planned
and marked on the skin before they are made. Ten centime-
ters anterior to the most posterior incision and along the
same rib (most commonly rib 8), a third incision is planned.
It is an incision for an 8-mm port, and its trocar is an 8-mmrdiovascular Surgery c Volume 142, Number 4 745
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Smetal reusable da Vinci trocar that will be docked with ro-
botic arm 2. A fourth incision is marked on the skin and
again planned but not made 9 cm anterior to this port, along
the same rib as shown in Figure 1. This will eventually be
used for the robotic camera. A 12-mm plastic disposable
port is used for the 12-mm camera, and if the 8-mm camera
is used, an 8-mm metal reusable trocar is placed. Before
these 2 incisions are made, a small 21-gauge needle is
used to identify the most anteriorly inferior aspect of the
chest that is just above the diaphragmatic fibers. This inci-
sion will have a 15-mm port and serve as the access port.
A plastic disposable trocar is used. No robotic arms are
attached to the trocar that is placed in this incision. This
incision is carefully planned. It is made just above the dia-
phragm, as anterior and inferior as possible and, importantly,
to be in between the ports used for robotic arm 1 and the746 The Journal of Thoracic and Cardiovascular Surgcamera. The access port can alternatively be more posterior
if anatomy dictates between the camera and robotic arm 2. It
should be 2 or 3 ribs lower than these 2 ports. This affords
room for the bedside assistant to work. Once these incisions
have been carefully planned and their locations have been
confirmed, they are made and the appropriate trocars are
placed. Finally, the initial 5-mm anterior port that was
made first and used to introduce theVATS camera to identify
the internal landmarks is then dilated to a 12-mm double-
cannulated port for robotic arm 1. The robot is driven over
the patient’s shoulder on a 15 angle and attached to the 4
ports. In general, only 4 robotic instruments were used for
all these operations: the Cadierre grasper, a 5-mm bowel
grasper (used exclusively through the most posterior port
that is attached to robotic arm 3, which serves as a retractor
of the lung), the Maryland forceps, and a cautery spatula.ery c October 2011
